of et al

Journal of Vascular Surgery
January 2018

randomized controlled trials, in a review of Medicare
patients, most major complications were lower with
EVAR, including pneumonia (3.8% vs 12.9%; P < .001),
acute renal failure (4.3% vs 11.3%; P < .001), MI (2.5% vs
5.2%; P < .00